01/24 | Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight .. | MT |
01/20 | Guggenheim Raises Price Target on BeiGene to $350 From $290, Maintains Buy Rating | MT |
01/20 | SVB Securities Adjusts Price Target on BeiGene to $300 From $236, Maintains Outperform .. | MT |
2022 | SVB Securities Adjusts BeiGene Price Target to $236 From $210, Maintains Outperform Rat.. | MT |
2022 | SVB Securities Adjusts Price Target on BeiGene to $210 From $200, Maintains Outperform .. | MT |
2022 | Nomura Adjusts BeiGene Price Target to $281.78 From $286.31, Maintains Buy Rating | MT |
2022 | Nomura Adjusts Beigene's Price Target to HK$170.15 From HK$172.89, Keeps at Buy | MT |
2022 | Morgan Stanley Raises BeiGene's Price Target to $295 From $290, Maintains Overweight Ra.. | MT |
2022 | Guggenheim Upgrades BeiGene to Buy From Neutral; Price Target is $205 | MT |
2022 | SVB Securities Upgrades BeiGene to Outperform From Market Perform, Adjusts Price Target.. | MT |
2022 | JPMorgan Assumes BeiGene at Overweight with $296 Price Target | MT |
2022 | Nomura Adjusts BeiGene's Price Target to $286.31 From $277.35, Maintains Buy Rating | MT |
2022 | Nomura Adjusts Beigene's Price Target to HK$172.89 From HK$167.48, Keeps at Buy | MT |
2022 | Analyst recommendations: Eli Lilly, KLA, Kellogg, Epam Systems, .. | |
2022 | Nomura Adjusts BeiGene's Price Target to $277.35 From $310.62, Maintains Buy Rating | MT |
2022 | Nomura Adjusts Beigene's Price Target to HK$167.48 From HK$186.85, Keeps at Buy | MT |
2022 | Morgan Stanley Adjusts BeiGene's Price Target to $293 from $300, Keeps Overweight Ratin.. | MT |
2022 | Morgan Stanley Adjusts Price Target for BeiGene to $293 From $300, Maintains Overweight.. | MT |
2022 | CMB International Starts BeiGene at Buy With $248.52 Price Target | MT |
2022 | Morgan Stanley Lowers BeiGene's Price Target to $300 From $338, Maintains Overweight Ra.. | MT |
2022 | Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Ratin.. | MT |
2022 | SVB Leerink Cuts BeiGene to Market Perform From Outperform, Price Target to $177 From $.. | MT |
2022 | Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to $310.62 From $293... | MT |
2022 | Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to HK$186.85 From HK$.. | MT |
2022 | Macquarie Lowers BeiGene's Price Target to $301.60 From $312.80, Maintains Outperform R.. | MT |
2022 | Morgan Stanley Lowers BeiGene's Price Target to $330 From $360, Maintains Overweight Ra.. | MT |
2022 | Goldman Sachs Lowers BeiGene's Price Target to $364.32 From $410.60, Maintains Buy Rati.. | MT |
2022 | SVB Leerink Adjusts BeiGene's Price Target to $300 from $334, Maintains Outperform Rati.. | MT |
2022 | Morgan Stanley Adjusts BeiGene's Price Target to $360 from $407, Keeps Overweight Ratin.. | MT |
2021 | Nomura Adjusts BeiGene's Price Target to $293.28 From $355.83, Maintains Neutral Rating | MT |
2021 | Nomura Adjusts Beigene's Price Target to HK$176.97 From HK$214.05, Keeps at Neutral | MT |
2021 | Nomura Adjusts BeiGene to Neutral From Not Rated, Sets $355.83 Price Target | MT |
2021 | BeiGene : SVB Leerink Adjusts Price Target on BeiGene to $414 From $417, Maintai.. | MT |
2021 | BeiGene : Bernstein Starts BeiGene at Outperform With $431 Price Target | MT |
2021 | BeiGene : Morgan Stanley Adjusts Price Target on BeiGene to $407 From $409, Main.. | MT |
2021 | BeiGene : SVB Leerink Adjusts BeiGene's Price Target to $417 from $388, Keeps Ou.. | MT |
2021 | BeiGene : Morgan Stanley Adjusts Price Target on BeiGene to $409 From $357, Main.. | MT |
2021 | BeiGene : Morgan Stanley Adjusts BeiGene's Price Target to $357 from $375, Keeps.. | MT |
2021 | BeiGene : HSBC Adjusts BeiGene's Price Target to $385 from $296, Keeps Buy Ratin.. | MT |
2021 | BeiGene : China Renaissance Initiates Coverage on BeiGene With Buy Rating | MT |
2021 | BeiGene : CLSA Downgrades BeiGene to Underperform From Outperform, Adjusts Price.. | MT |
2021 | BeiGene : Cowen & Co. Adjusts Price Target on BeiGene to $429 From $348, Maintai.. | MT |
2021 | BeiGene : Morgan Stanley Adjusts BeiGene PT to $375 From $310, Maintains Overwei.. | MT |
2020 | BeiGene : Ladenburg Thalmann Upgrades BeiGene to Buy From Neutral; Price Target .. | MT |
2020 | BeiGene : SVB Leerink Adjusts BeiGene's Price Target to $327 From $240, Keeps at.. | MT |
2020 | BeiGene : Morgan Stanley Adjusts BeiGene PT to $310 From $270, Maintains Overwei.. | MT |
2020 | BeiGene : Ladenburg Thalmann Downgrades BeiGene to Neutral from Buy | MT |
2020 | BeiGene : Piper Sandler Downgrades BeiGene to Underweight From Neutral; Price Ta.. | MT |